Maxygen

company

About

Maxygen is a contract research organization specializing in directed evolution services for protein engineering.

  • 51 - 100

Highlights

Details

Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 1996
Number Of Employee
51 - 100
Operating Status
Close

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs through both internal development and external collaborations and other arrangements. They use their MolecularBreedingâ„¢ directed evolution technology platform, along with ancillary technologies, and extensive protein modification expertise to pursue the creation of biosuperior proteins.

Investments

Number of Investments
Number of Lead Investments
1
0
Maxygen has made 1 investments. Their most recent investment was on Aug 14, 2006, when Codexis raised $37M.
Date Company Name
Round Money Raised Industry Lead Investor
Aug 14, 2006 Codexis
Series D $37M Biotechnology